Abstract
Leishmaniasis is a parasitic disease caused by different species of protozoan parasites belonging to the genus Leishmania. In this study, Leishmania major (MRHO/IR/75/ER) promastigotes were cultured at 23–25 °C in brain heart infusion (BHI) medium supplemented with 10 % heat-inactivated fetal bovine serum (FBS) and penicillin and streptomycin. Antileishmanial effects of Lowsonia inermis and Cedrus libani methanolic extracts (0.07, 0.15, 0.31, 0.62, 1.25, 2.5, 5, 10 mg/mL) on Leishmania major promastigotes were evaluated using the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. All experiments were repeated at least three times. Cedrus libani methanolic extract did not show any activity while Lowsonia inermis methanolic extract inhibited the growth of promastigote forms of L. major in vitro after 72 h of incubation and had a 50 % inhibitory concentration (IC50) of 1.25 mg/mL. The methanolic extract of Lawsonia inermis (henna) can be a promising antileishmanial agent in the future. Further experiments are needed for isolation of active fractions and identification of the active components of methanolic extract.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N (2004) In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar. Ann Clin Microbiol Antimicrob 3:27–31
Barati M, Sharifi I, Sharififar F, Hakimi Parizi M, Shokri A (2014) Anti-leishmanial Activity of Gossypium hirsutum L., Ferula assa-foetida L. and Artemisia aucheri Boiss. Extracts by colorimetric assay. Anti-Infect Agents 12:159–164
Berman J (1988) Chemotherapy for leishmaniasis: biochemical mechanism, clinical efficacy and future strategies. Rew Infect Dis 10:560–585
Berman J (2003) Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 16:397–401
Caio E, Lima D, Kaplan MAC, Nazareth M, Rossi-Bergmann B (1999) Selective effect of 2′, 6′-dihydroxy- 4′methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother 43:1234–1241
Carvalho PB, Ferreira EI (2001) Leishmaniasis phytotherapy. Natureʼ s leadership against an ancient disease. Fitoterapia 72:599–618
Chan-Bacab MJ, Pena-Rodriguez LM (2001) Plant natural products with leishmanicidal activity. Nat Prod Rep 18:674–688
Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, da Cunha Pinto A, Henriques AT, Bou-Habib DC, Saraiva EM (2001) Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 45:1349–1354
Digrak M, Ilcim A, Hakki Alma M (1999) Antimicrobial activities of several parts of Pinus brutia, Juniperus oxycedrus, Abies cilicia, Cedrus libani and Pinus nigra. Phytother Res 13:584–587
Dinesh Babu P, Subhasree RS (2009) Antimicrobial activities of Lawsonia inermis—a Review. Acad J Plant Sci 2:231–232
Edzard E (1998) Harmless herbs? A review of the recent literature. Am J Med 104:170–178
Evans DA (1989) Handbook on isolation, characterization and cryopreservation of Leishmania. UNDP/World Bank/WHO special program for research and training in Tropical Disease (TDR), Geneva
Ezatpour B, Saedi Dezaki E, Mahmoudvand H, Azadpour M, Ezzatkhah F (2015) In vitro and in vivo Antileishmanial effects of Pistacia khinjuk against Leishmania tropica and Leishmania major. Evid Based Complement Alternat Med. doi:10.1155/2015/149707
Guerin PJ, Olliaro P, Sunder S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD (2002) Visceral leishmaniasis: current status of control, diagnosis and development agenda. Lancet Infect Dis 2:494–501
Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug resistant Leishmania tropica parasites. PLOS Med 3:e162
Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191–1199
Kizil M, Kizil G, Yavuz M, Aytekin C (2002) Antimicrobial activity of the resins obtained from the roots and stems of Cedrus libani and Abies cilicica. Prikl Biokhim Mikrobiol 38:166–168
Maes L, Vanden Berghe D, Germonprez N, Quirijnen L, Cos P, de Kimpe N, Van Puyvelde L (2004) In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species. Antimicrob Agent Chemother 48:130–136
Mahmoudvand H, Sharififar F, Rahmat MS, Tavakoli R, Dezaki ES, Jahanbakhsh S, Sharifi I (2014) Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica. J Vector Borne Dis 51:294–299
Mirzaie M, Nosratabadi SJ, Derakhshanfar A, Sharifi I (2007) Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug. Veterinarski Arhiv 77:365–375
Mohebali M, Javadian E, Yaghoobi-Ershadi MR, Akhavan AA, Hajjaran H, Abaei MR (2004) Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran. East Mediterr Health J 10:591–599
Mohebali M, Fotouhi A, Hooshmand B, Zarei Z, Akhoundi B, Rahnema A, Razaghian AR, Kabir MJ, Nadim A (2007) Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop 103:33–40
Nosratabadi SJ, Sharifi I, Sharififar F, Bamorovat M, Daneshvar H, Mirzaie M (2015) In vitro antileishmanial activity of methanolic and aqueous extracts of Eucalyptus camaldulensis against Leishmania major. J Parasit Dis 39:18–21
Rates SMK (2001) Plants as source of drugs. Toxicon 39:603–613
Riffel A, Medina LF, Stefani V, Santos RC, Bizani D, Brandelli A (2002) In vitro antimicrobial activity of a new series of 1,4-naphthoquinones. Braz J Med Biol Res 35:811–818
Scarisbrick JJ, Chiodini PL, Watson J, Moody A, Armstrong M, Lockwood D, Bryceson A, Vega-López F (2006) Clinical features and diagnosis of 42 travelers with cutaneous leishmaniasis. Travel Med Infect Dis 4:14–21
The world health report (2004) Changing history. WHO, Geneva. http://www.who.int/whr/2004/en/index.html. Accessed 12 June 2007
Tiuman TS, Ueda-Nakamura T, Garcia Cortez DA, Dias Filho BP, Morqado-Diaz JA, de Souza W, Nakamura CV (2005) Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agent Chemother 49:176–182
Tripathi RD, Srivastava HS, Dixit SN (1978) A fungitoxic principle from the leaves of Lawsonia inermis Linn. Experientia 1(5):51–52
Wright CW, Phillipson JD (1990) Natural products and the development of selective antiprotozoal drugs. Phytotherapy 4:127–139
Acknowledgments
We thank the Office of the Vice-Chancellors for Research of Shiraz University of Medical Sciences for financial support of the project 87-4105.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Motazedian, M.H., Mikaeili, F., Mohebali, M. et al. The antileishmanial effects of Lowsonia inermis and Cedrus libani on Leishmania major promastigotes: an in vitro study. J Parasit Dis 41, 375–379 (2017). https://doi.org/10.1007/s12639-016-0809-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12639-016-0809-y